BerandaGLPGF • OTCMKTS
add
Galapagos NV
Tutup sebelumnya
$31,29
Rentang tahun
$22,39 - $33,45
Kapitalisasi pasar
2,19 M USD
Volume Rata-Rata
33,00
Rasio P/E
-
Hasil dividen
-
Bursa utama
AMS
Berita pasar
Keuangan
Laporan Laba Rugi
Pendapatan
Penghasilan bersih
| (EUR) | Sep 2025info | Perubahan Y/Y |
|---|---|---|
Pendapatan | 71,16 jt | 18,90% |
Biaya operasional | 28,10 jt | 33,26% |
Penghasilan bersih | -202,11 jt | -300,78% |
Margin laba bersih | -284,02 | -237,08% |
Penghasilan per saham | -0,18 | 75,95% |
EBITDA | -33,23 jt | 31,45% |
Tarif pajak efektif | 7,90% | — |
Neraca
Total aset
Total liabilitas
| (EUR) | Sep 2025info | Perubahan Y/Y |
|---|---|---|
Investasi tunai jangka pdk | 3,05 M | -8,65% |
Total aset | 3,51 M | -15,83% |
Total liabilitas | 1,06 M | -18,68% |
Total ekuitas | 2,45 M | — |
Saham yang beredar | 65,89 jt | — |
Harga terhadap nilai buku | 0,84 | — |
Tingkat pengembalian aset | -2,84% | — |
Tingkat pengembalian modal | -4,08% | — |
Arus Kas
Perubahan kas bersih
| (EUR) | Sep 2025info | Perubahan Y/Y |
|---|---|---|
Penghasilan bersih | -202,11 jt | -300,78% |
Kas dari operasi | -62,61 jt | 12,79% |
Kas dari investasi | 56,74 jt | 0,32% |
Kas dari pembiayaan | -1,26 jt | -15,53% |
Perubahan kas bersih | -7,21 jt | 57,09% |
Arus kas bebas | -62,98 jt | 5,41% |
Tentang
Galapagos NV is a Belgian pharmaceutical research company which was founded in 1999. Its headquarters are located in Mechelen and has additional locations in Leiden, Romainville, Basel, Milan, Madrid, Boston and Zagreb.
The company develops drugs against rheumatoid arthritis, Crohn's disease, ulcerative colitis, psoriasis, systemic lupus erythematosus and cystic fibrosis. Wikipedia
Didirikan
1999
Situs
Karyawan
558
